Close

Pfizer (PFE) to Acquire Commercializatoin Rights of Glatiramer Acetate

August 3, 2015 8:35 AM EDT Send to a Friend
Pfizer (NYSE: PFE) and Synthon, an international pharmaceutical company specializing in the development of complex generic medicines, announced they have ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login